Rekha Bansal
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$6.9MFederal grants as PI8 awards
11Patents grantedLatest May 14, 2024
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
8 awards · $6.9M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Jul 15, 2021 | NIH | SBIR Phase I Disease Modifying Treatment for Hemolytic Disorders | $533K | Novelmed Therapeutics Inc |
| Jul 9, 2021 | NIH | SBIR Phase II Disease Modifying Treatment for Hemolytic Disorders | $533K | Novelmed Therapeutics Inc |
| Jun 1, 2021 | NIH | SBIR Phase II Treatment of Complement-Mediated Myelitis | $300K | Novelmed Therapeutics Inc |
| Feb 28, 2017 | NIH | SBIR Phase II Preclinical and Clinical Evaluation of Humanized NM9405 | $1.3M | Novelmed Therapeutics Inc |
| Sep 15, 2015 | NIH | SBIR Phase II Single Therapy for Wet AMD & Geographic Atrophy | $39K | Novelmed Therapeutics Inc |
| Sep 4, 2015 | NIH | SBIR Phase II Novel Treatments to Abolish Inflammatory Mediators in Hemodialysis | $602K | Novelmed Therapeutics Inc |
| Mar 20, 2015 | NIH | SBIR Phase II Preclinical and Clinical Evaluation of Humanized NM9405 | $1.2M | Novelmed Therapeutics Inc |
| Mar 1, 2015 | NIH | SBIR Phase II Preclinical and Clinical Evaluation of Humanized NM | $2.4M | Novelmed Therapeutics Inc |
12 patents as inventor
- US 10131706Novelmed Therapeutics IncNov 20, 2018
- US 10183989Novelmed Therapeutics IncJan 22, 2019
- US 10696740Novelmed Therapeutics IncJun 30, 2020
- US 10711056Novelmed Therapeutics IncJul 14, 2020
- US 10858420Novelmed Therapeutics IncDec 8, 2020
- US 11981727Novelmed Therapeutics IncMay 14, 2024
- US 9243060Novelmed Therapeutics IncJan 26, 2016
- US 9676842Novelmed Therapeutics IncJun 13, 2017
- US 9816999Novelmed Therapeutics IncNov 14, 2017
- US 9926366Novelmed Therapeutics IncMar 27, 2018
- US 9988441Novelmed Therapeutics IncJun 5, 2018
- US Novelmed Therapeutics Inc—
Matched by the first inventor’s name and the patent’s company.
Peer ranks
Federal funding#146
Awards as PI#190
Patents#4
Companies
- Novelmed Therapeutics IncLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.